NBP - NovaBridge Biosciences • Growth
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
-100%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
20,5%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
65,9%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!